Leukemia Research
Volume 23, Issue 8 , Pages 701-707 , August 1999

The importance of cell size and surface marker analysis in childhood acute myeloblastic leukemia

  • Lale Olcay

      Affiliations

    • Division of Pediatric Hematology, Department of Pediatrics, Hacettepe University, Faculty of Medicine, Ankara, Turkey
    • ,
  • Ulya Ertem

      Affiliations

    • Division of Oncology, Doctor Sami Ulus Children’s Hospital, Ankara, Turkey
    • ,
  • Hamza Okur

      Affiliations

    • Division of Pediatric Hematology, Department of Pediatrics, Hacettepe University, Faculty of Medicine, Ankara, Turkey
    • ,
  • A.Murat Tuncer

      Affiliations

    • Division of Pediatric Hematology, Department of Pediatrics, Hacettepe University, Faculty of Medicine, Ankara, Turkey
    • Corresponding Author InformationCorresponding author. Present address: Institute of Child Health, Hacettepe Children’s Hospital, 06100 Ankara, Turkey. Tel.: +90-312-324-1681; fax: +90-312-324-3284

Received 28 July 1998 ,Accepted 5 February 1999.

References 

  1. Rowe JM, Liesveld JL. Treatment and prognostic factors in acute myeloid leukaemia. In:  Löwenberg B editors. Acute Myelogenous Leukaemia and Myelodysplasia. London: Bailliere Tindall, W.B., Saunders Company Ltd; 1996;p. 87
  2. Kawada H, Ichikawa Y, Watanabe S, Nagao T, Arımorı S. Flow cytometric analysis of cell-surface antigen expressions on acute myeloid leukemia cell populations according to their cell-size. Leuk. Res. 1994;18:29
  3. Olcay L, Tuncer AM. Cell size and prognosis in childhood AML. Leuk. Res. 1995;19:581
  4. Lee SL, Kopel S, Glidewell O. Cytomorphological determinants of prognosis in acute lymphoblastic leukemia of children. Semin. Oncol. 1976;3:209
  5. Kwong YL, Lam CK, Chan AYY, Lie AKW, Chan LC. Cytogenetic triclonality in acute myeloid leukemia: a morphologic, immunologic and in situ hybridization study. Cancer Genet. Cytogenet. 1994;72:86
  6. Hiçsönmez G, Tuncer AM, Çetin M, Özbek N, Gümrük F. Eight-year experiences with HDMP as a differentiation inducer in childhood AML. Differentiation therapy. In:  Waxman S editors. Challenges of Modern Medicine. 10:New York: Ares-Serono Symposia Publications; 1995;p. 471
  7. Woods WG, Ruymann FB, Lampkin BC, Buckley JD, Bernstein ID, Srivastava AK, et al.  The role of timing high dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemia. Cancer. 1990;66:1106
  8. Ormerod MG. Preparing suspensions of single cells. In:  Ormerod MG editors. Flow Cytometry. 2nd edition. Oxford: Oxford University Press; 1994;p. 45
  9. Gavosto F, Pileri A, Bachi C, Pegoraro L. Proliferation and maturation defect in acute leukaemia cells. Nature. 1964;203:92
  10. Terasima T, Tolmach LJ. Growth and nucleic acid synthesis in synchronously dividing populations of HeLa cells. Exp. Cell Res. 1963;30:344
  11. Minden MD, Till JE, McCulloch EA. Proliferative state of blast cell progenitors in acute myeloblastic leukemia (AML). Blood. 1978;52:592
  12. Campos L, Ffrench M, Guyotat D. Myeloid differentiation antigens identify leukemic cell subpopulations with different cell cycle characteristics. Leukemia. 1990;4:60
  13. Lanier LL, Warner NL. Cell cycle related heterogeneity of Ia antigen expression on a murine B lymphoma cell line: analysis by flow cytometry. J. Immunol. 1981;126:626
  14. Takase K, Okawa H, Minato K, Yata J. Cell cycle-related expression of surface antigens on myelomonocytic leukemia cells. Leuk. Res. 1988;12:583
  15. Everson LK, Plocinik BA, Rogentine GN. HL-A expression on the G1, S, and G2 cell-cycle stages of human lymphoid cells. J.Natl Cancer Inst. 1974;73:913
  16. Smith FO, Lampkin BC, Versteeg C, Flowers DA, Dinndorf PA, Buckley JD, et al.  Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cells lacks prognostic significance. Blood. 1992;79:2415
  17. Kuerbitz SJ, Civin CI, Krischer JP, Ravindranath Y, Steuber CP, Weinstein HJ, et al.  Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group Study. J. Clin. Oncol. 1992;10:1419
  18. Drexler HG, Thiel E, Ludwig WD. Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance. Leukemia. 1993;7:489
  19. Kwong YL, Chan AYY, Chan LC, Wong KF, Chu YC. Near-triploid myeloblastic transformation of chronic myeloid leukemia with bizarre blast morphology. Cancer Genet. Cytogenet. 1992;58:92
  20. Clarke MR, Lynch EF, Contis LC, Sherer ME, Shekhter-Levin S. Near-tetraploidy in adult acute myelogenous leukemia. Cancer Genet. Cytogenet. 1996;86:107
  21. Terstappen LWMM, Könemann S, Safford M, Loken MR, Zurlutter K, Büchner Th, et al.  Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties. Leukemia. 1991;5:315
  22. Vidriales MB, Orfao A, L’opez-Berges MC, Gonz’alez M, L’opez-Macedo A, Garc’ia MA, et al.  Light scatter characteristics of blast cells in acute myeloid leukemia: association with morphology and immunophenotype. J. Clin. Pathol. 1995;48:456

PII: S0145-2126(99)00053-3

Leukemia Research
Volume 23, Issue 8 , Pages 701-707 , August 1999

Article Tools